Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT01069432

Protocol to Obtain Blood for Discovery of Novel Biomarkers and Potential Therapeutic Targets in Chronic Lymphocytic Leukemia

Status
Withdrawn
Phase
—
Study type
Observational
Enrollment
0 (actual)
Sponsor
Dartmouth-Hitchcock Medical Center · Academic / Other
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to collect a blood sample from patients with Chronic Lymphocytic Leukemia (CLL) and from volunteers without CLL.

Detailed description

The blood sample will be used in the laboratory to perform focused studies on Chronic Lymphocytic Leukemia (CLL).

Conditions

Interventions

TypeNameDescription
OTHERNo InterventionNo Intervention

Timeline

Start date
2010-05-01
Primary completion
2011-02-01
Completion
2011-02-01
First posted
2010-02-17
Last updated
2018-03-19

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT01069432. Inclusion in this directory is not an endorsement.

Protocol to Obtain Blood for Discovery of Novel Biomarkers and Potential Therapeutic Targets in Chronic Lymphocytic Leuk (NCT01069432) · Clinical Trials Directory